Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 News-Press Now
View original post here:
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - News-Press Now
What is prediabetes and what can you do to stop it? The Independent
Read this article:
What is prediabetes and what can you do to stop it? - The Independent
Diabetes symptoms: 6 high blood sugar warning signs that show on hand and feet India.com
Read more here:
Diabetes symptoms: 6 high blood sugar warning signs that show on hand and feet - India.com
'Fix Broken Food System!' Government Urged as Study Says 1 in 5 Brits Affected by Diabetes Men's Health UK
The #1 Habit for Better Heart Health If You Have Diabetes, According to Experts EatingWell
See original here:
The #1 Habit for Better Heart Health If You Have Diabetes, According to Experts - EatingWell
Have you ever wondered about the future of medicine where healing is not just about managing symptoms, but regenerating lost or damaged tissues? Imagine a world where human tissues could be regrown, organs regenerated, or chronic conditions reversed. This is the promise of regenerative medicine, a rapidly advancing field that is reshaping the landscape of healthcare.
Regenerative medicine is revolutionizing the way we think about healing, offering hope for patients with injuries, degenerative diseases, or conditions previously considered incurable. It involves harnessing the bodys natural healing abilities to repair, replace, or regenerate damaged tissues and organs. But what exactly are the different types of regenerative medicine, and how do they work?
In this comprehensive guide, we will explore the various types of regenerative medicine, their applications, and the scientific breakthroughs making them a reality.
Regenerative medicine encompasses a variety of technologies and strategies that aim to restore the structure and function of damaged tissues and organs. Broadly speaking, there are several types of regenerative medicine, each with its unique approach and potential applications. These can be categorized into three main groups:
Lets dive into each of these types to understand their mechanisms, applications, and future potential.
Stem cell therapy is often considered the cornerstone of regenerative medicine. Stem cells have the remarkable ability to develop into different types of cells in the body, making them incredibly valuable for regenerative applications.
Stem cells are unspecialized cells that have the potential to differentiate into specialized cells with specific functions. There are two main types of stem cells used in regenerative medicine:
Stem cell therapy is being used in a wide range of applications, including:
Despite the exciting possibilities, there are challenges to stem cell therapy, including immune rejection, ethical concerns, and the need for better control over stem cell differentiation.
However, ongoing research is addressing these issues, and stem cell therapy is expected to become more effective and widely available in the future.
Tissue engineering is another pillar of regenerative medicine. This approach involves using a combination of cells, biomaterials, and growth factors to create functional tissues and organs. The goal is to replicate the complex structures of natural tissues and replace damaged ones.
Tissue engineering involves three main components:
By combining these components, tissue engineers create structures that mimic the natural architecture of tissues such as skin, bone, and blood vessels.
Tissue engineering holds immense promise in the creation and repair of tissues and organs, including:
Although tissue engineering has made significant strides, there are still challenges in creating fully functional, complex tissues and organs. The need for better biomaterials, vascularization (blood supply), and long-term viability of engineered tissues is a major hurdle.
However, innovations in 3D printing, biomaterials, and gene editing hold great promise for overcoming these obstacles.
Gene therapy is an emerging field that involves the introduction or alteration of genetic material within a patients cells to treat or prevent diseases. In regenerative medicine, gene therapy is used to stimulate the regeneration of tissues or repair genetic defects that hinder tissue healing.
Gene therapy works by delivering specific genes into a patients cells to promote tissue repair or regeneration. This can be done using several methods:
The goal is to use gene therapy to either:
Gene therapy is being used to treat a variety of conditions, including:
While gene therapy holds immense potential, there are still several challenges, such as ensuring the safe and effective delivery of genes, avoiding immune responses, and addressing ethical concerns surrounding genetic manipulation.
Despite these hurdles, gene therapy is poised to become an essential tool in regenerative medicine, with the potential to treat a wide range of genetic and degenerative diseases.
Regenerative medicine is advancing at an unprecedented pace, and the future looks promising. As research continues to unlock the full potential of stem cells, tissue engineering, and gene therapy, we can expect to see:
Regenerative medicine is no longer a distant dream; it is a rapidly growing field that promises to revolutionize healthcare. Whether through stem cell therapy, tissue engineering, or gene therapy, the ability to regenerate damaged tissues and organs holds immense potential to change the lives of millions.
While challenges remain, the continuous progress in this area offers hope for curing diseases and repairing injuries that once seemed impossible. The future of regenerative medicine is bright, and its transformative impact on medicine, healthcare, and quality of life cannot be overstated.
References:
See more here:
101 Guide to Regenerative Medicine Types | Applications, Challenges
Regenerative Medicine aims to leverage the bodys innate healing mechanisms to repair, replace, or regenerate tissues and organs with damage or disease. This approach utilizes a variety of techniques including tissue engineering, gene therapy, and biomaterials to trigger the bodys regenerative processes.
Unlike traditional symptomatic treatments, it targets the root cause of ailments affecting muscles, cartilage, tendons, and ligaments, thereby stimulating and accelerating the bodys natural healing abilities.
At ASCPM, board-certified physicians bring years of expertise in minimally invasive procedures, with a focus on regenerative therapies. Through regular training, the ASCPM team stays abreast of the most effective techniques in Regenerative Medicine, ensuring optimal healing outcomes for patients.
Regenerative Procedures:
See the original post:
Regenerative Medicine | What is it? | ASCPM
What is regeneratvie medicine and advanced therapy?
Credit: AdobeStock
Regenerative medicine therapy, including cell therapy, gene therapy, and therapeutic tissue engineering, provides unprecedented potential to treat, modify, reverse, or cure previously intractable diseases, such as cancer and organ failures. This class of therapy has completely changed the paradigm and the trajectory for medical treatment. Broad clinical translation and patient access requires advances in manufacturing technologies and measurements to ensure the safety, quality, and consistency of the therapy and to reduce the cost.
NIST is committed to solving the measurement challenges of this fast-moving sector of the bioeconomy by providing underpinning measurement infrastructure and platform technologies, as well as standards to promote manufacturing innovation, improve supply chain resilience, and support characterization and testing to facilitate regulatory approval.
The NIST Regenerative Medicine program is working closely with the U.S. Food and Drug Administration'sCenter for Biologics Evaluation and Research(FDA/CBER) and the Standards Coordinating Body (SCB) as well as the broader industry to develop global manufacturing and measurement standards underpinned by a robust measurement infrastructure needed to advance product development and translation as directed by Sec. 3036 of the 21st Century Cures Act.
The NIST laboratory programs support this growing industry as well as the broader industry ecosystem by:
Originally posted here:
Regenerative medicine and advanced therapy | NIST
Therapeutic reprogramming represents a transformative paradigm in regenerative medicine, developing new approaches in cell therapy, small molecule drugs, biologics, and gene therapy to address unmet medical challenges. This paradigm encompasses the precise modulation of cellular fate and function to either generate safe and functional cells ex vivo for cell-based therapies or to directly ...
See the article here:
Therapeutic Reprogramming toward Regenerative Medicine
UNIVERSITY PARK, Pa. A biomaterial that can mimic certain behaviors within biological tissues could advance regenerative medicine, disease modeling, soft robotics and more, according to researchers at Penn State.
Materials created up to this point to mimic tissues and extracellular matrices (ECMs) the bodys biological scaffolding of proteins and molecules that surrounds and supports tissues and cells have all had limitations that hamper their practical applications, according to the team. To overcome some of those limitations, the researchers developed a bio-based, living material that encompasses self-healing properties and mimics the biological response of ECMs to mechanical stress.
They published their results in Materials Horizons, where the research was also featured on the cover of the journal.
We developed a cell-free or acellular material that dynamically mimics the behavior of ECMs, which are key building blocks of mammalian tissues that are crucial for tissue structure and cell functions, said corresponding author Amir Sheikhi, associate professor of chemical engineering and the Dorothy Foehr Huck and J. Lloyd Huck Early Career Chair in Biomaterials and Regenerative Engineering.
According to the researchers, previous iterations of their material a hydrogel, or water-rich polymer network were synthetic and lacked the desired combination of mechanical responsiveness and biological mimicry of ECMs.
Specifically, these materials need to replicate nonlinear strain-stiffening, which is when ECM networks stiffen under strain caused by physical forces exerted by cells or external stimuli, Sheikhi said, explaining nonlinear strain-stiffening is important for providing structural support and facilitating cell signaling. The materials also need to replicate the self-healing properties necessary for tissue structure and survival. Prior synthetic hydrogels had difficulties in balancing material complexity, biocompatibility and mechanical mimicry of ECMs.
The team addressed these limitations by developing acellular nanocomposite living hydrogels (LivGels) made from hairy nanoparticles. The nanoparticles are composed of nanocrystals, or nLinkers, with disordered cellulose chains, or hairs, at the ends. These hairs introduce anisotropy, meaning the nLinkers have different properties depending on their directional orientation and allow dynamic bonding with biopolymer networks. In this case, the nanoparticles bonded with a biopolymeric matrix of modified alginate, which is a natural polysaccharide found in brown algae.
These nLinkers form dynamic bonds within the matrix that enable strain-stiffening behavior, that is, mimicking ECM's response to mechanical stress; and self-healing properties, which restore integrity after damage, Sheikhi said, noting that the researchers used rheological testing, which measures how material behaves under various stressors, to measure how rapidly the LivGels recovered their structure after high strain. This design approach allowed fine-tuning of the material's mechanical properties to match those of natural ECMs.
Excerpt from:
Novel living biomaterial aims to advance regenerative medicine
Irvine, Calif., Jan. 9, 2025 An international research team led by the University of California, Irvine has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue engineering.
Most cartilage relies on an external extracellular matrix for strength, but lipocartilage, which is found in the ears, nose and throat of mammals, is uniquely packed with fat-filled cells called lipochondrocytes that provide super-stable internal support, enabling the tissue to remain soft and springy similar to bubbled packaging material.
The study, published online today in the journal Science, describes how lipocartilage cells create and maintain their own lipid reservoirs, remaining constant in size. Unlike ordinary adipocyte fat cells, lipochondrocytes never shrink or expand in response to food availability.
Lipocartilages resilience and stability provide a compliant, elastic quality thats perfect for flexible body parts such as earlobes or the tip of the nose, opening exciting possibilities in regenerative medicine and tissue engineering, particularly for facial defects or injuries, said corresponding author Maksim Plikus, UC Irvine professor of developmental and cell biology. Currently, cartilage reconstruction often requires harvesting tissue from the patients rib a painful and invasive procedure. In the future, patient-specific lipochondrocytes could be derived from stem cells, purified and used to manufacture living cartilage tailored to individual needs. With the help of 3D printing, these engineered tissues could be shaped to fit precisely, offering new solutions for treating birth defects, trauma and various cartilage diseases.
Dr. Franz Leydig first recognized lipochondrocytes in 1854, when he noted the presence of fat droplets in the cartilage of rat ears, a finding that was largely forgotten until now. With modern biochemical tools and advanced imaging methods, UC Irvine researchers comprehensively characterized lipocartilages molecular biology, metabolism and structural role in skeletal tissues.
They also uncovered the genetic process that suppresses the activity of enzymes that break down fats and reduce the absorption of new fat molecules, effectively locking lipochondrocytess lipid reserves in place. When stripped of its lipids, the lipocartilage becomes stiff and brittle, highlighting the importance of its fat-filled cells in maintaining the tissues combination of durability and flexibility. In addition, the team noted that in some mammals, such as bats, lipochondrocytes assemble into intricate shapes, like parallel ridges in their oversized ears, which may enhance hearing acuity by modulating sound waves.
The discovery of the unique lipid biology of lipocartilage challenges long-standing assumptions in biomechanics and opens doors to countless research opportunities, said the studys lead author, Raul Ramos, a postdoctoral researcher in the Plikus laboratory for developmental and regenerative biology. Future directions include gaining an understanding of how lipochondrocytes maintain their stability over time and the molecular programs that govern their form and function, as well as insights into the mechanisms of cellular aging. Our findings underscore the versatility of lipids beyond metabolism and suggest new ways to harness their properties in tissue engineering and medicine.
The team included healthcare professionals and academics from the U.S., Australia, Belarus, Denmark, Germany, Japan, South Korea and Singapore, as well as staff from the Serrano Animal & Bird Hospital in Lake Forest and the Santa Ana Zoo. See the full list here.
This work was supported in part by the W.M. Keck Foundation under grant WMKF-5634988; UCI Beall Applied Innovation under Proof of Product grant IR-PR57179; LEO Foundation grants LF-AW-RAM-19-400008 and LF-OC-20-000611; Chan Zuckerberg Initiative grant AN-0000000062; Horizon Europe grant 101137006; National Institutes of Health grants U01-AR073159, R01- AR079470, R01-AR079150, R21-AR078939, P30-AR075047, R01-AR078389-01, R01-DE015038, R01-AR071457, R01-AR067821, R01GM152494, R01DE030565, TL1-TR001415, R01-DE013828, R01- DE30565, R01-HD073182, R01-AR067797, R01-DE017914 and MBRS-IMSD training grant GM055246; National Science Foundation grants DMS1951144, IOS-2421118, DMS1763272, CBET2134916, NSF-GRFP DGE-1321846 and MCB 2028424. Additional backing came from Simons Foundation grant 594598, the Yoshida Scholarship Foundation, a Howard A. Scheiderman Fellowship Award, the Ben F. Love Chair in Cancer Research at Baylor College of Medicine, the UC Riverside School of Medicine Deans Postdoc to Faculty Program and the Danish Cancer Society.
About UC Irvines Brilliant Future campaign:Publicly launched on Oct. 4, 2019, the Brilliant Future campaign aims to raise awareness and support for UC Irvine. By engaging 75,000 alumni and garnering $2 billion in philanthropic investment, UC Irvine seeks to reach new heights of excellence instudent success, health and wellness, research and more. The Charlie Dunlop School of Biological Sciences plays a vital role in the success of the campaign. Learn more by visitinghttps://brilliantfuture.uci.edu/school-of-biological-sciences.
About the University of California, Irvine:Founded in 1965, UC Irvine is a member of the prestigious Association of American Universities and is ranked among the nations top 10 public universities byU.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UC Irvine has more than 36,000 students and offers 224 degree programs. Its located in one of the worlds safest and most economically vibrant communities and is Orange Countys second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide.For more on UC Irvine, visitwww.uci.edu.
Media access: Radio programs/stations may, for a fee, use an on-campus studio with a Comrex IP audio codec to interview UC Irvine faculty and experts, subject to availability and university approval. For more UC Irvine news, visitnews.uci.edu. Additional resources for journalists may be found athttps://news.uci.edu/media-resources.
Read more:
UC Irvine-led discovery of new skeletal tissue advances regenerative ...
Azimi B, Sorayani Bafqi MS, Fusco A, Ricci C, Gallone G, Bagherzadeh R, et al. Electrospun ZnO/Poly(Vinylidene Fluoride-Trifluoroethylene) scaffolds for lung tissue Engineering. Tissue Eng Part A. 2020;26(2324):131231.
Article CAS PubMed Google Scholar
Poon J. Tissue Engineering Architectural cues for in vitro models of respiratory epithelium. University of Toronto (Canada); 2018.
Shirani A, Ganji F, Golmohammadi M, Hashemi SM, Mozafari M, Amoabediny G, et al. Cross-linked acellular lung for application in tissue engineering: effects on biocompatibility, mechanical properties and immunological responses. Mater Sci Eng C Mater Biol Appl. 2021;122:111938.
Article CAS PubMed Google Scholar
Tebyanian H, Karami A, Nourani MR, Motavallian E, Barkhordari A, Yazdanian M, et al. Lung tissue engineering: an update. J Cell Physiol. 2019;234(11):1925670.
Article CAS PubMed Google Scholar
Raredon MSB, Yuan Y, Niklason LE. Chapter 68 - lung tissue engineering. In: Lanza R, Langer R, Vacanti JP, Atala A, editors. Principles of tissue Engineering. Fifth Edition): Academic; 2020. pp. 127385.
Chapter Google Scholar
Matai I, Kaur G, Seyedsalehi A, McClinton A, Laurencin CT. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials. 2020;226:119536.
Article CAS PubMed Google Scholar
Zolbin MM, Daghigh F, Shojaie L, Ekhtiyari M, Kajbafzadeh AM. Fetal lung tissue Engineering. Adv Exp Med Biol. 2021;1345:1733.
Article CAS PubMed Google Scholar
Nakamura T, Sato T, Araki M, Ichihara S, Nakada A, Yoshitani M, et al. In situ tissue engineering for tracheal reconstruction using a luminar remodeling type of artificial trachea. J Thorac Cardiovasc Surg. 2009;138(4):8119.
Article PubMed Google Scholar
Nomoto Y, Suzuki T, Tada Y, Kobayashi K, Miyake M, Hazama A, et al. Tissue engineering for regeneration of the tracheal epithelium. Ann Otol Rhinol Laryngol. 2006;115(7):5016.
Article PubMed Google Scholar
Rahmati M, Pennisi CP, Mobasheri A, Mozafari M. Bioengineered scaffolds for Stem Cell Applications in tissue Engineering and Regenerative Medicine. Adv Exp Med Biol. 2018;1107:7389.
Article CAS PubMed Google Scholar
Bolte C, Kalin TV, Kalinichenko VV. Molecular, cellular, and bioengineering approaches to stimulate lung regeneration after injury. Semin Cell Dev Biol. 2020;100:1018.
Article CAS PubMed Google Scholar
Hu Q, Zhang S, Yang Y, Yao JQ, Tang WF, Lyon CJ, et al. Extracellular vesicles in the pathogenesis and treatment of acute lung injury. Military Med Res. 2022;9(1):61.
Article Google Scholar
Tang QY, Wei JX, Xue SF, Liu GH, Fu LX. Fibrogrowth factor-2 protects against acute lung injury by activating the PI3K/Akt signaling pathway. J Biol Regul Homeost Agents. 2020;34(5):167988.
CAS PubMed Google Scholar
van der Koog L, Boerrigter MJ, Gorter IC, Gosens R, Nagelkerke A. Lung fibroblast-derived extracellular vesicles and soluble factors alleviate elastase-induced lung injury. Eur J Pharmacol. 2024;974:176612.
Article PubMed Google Scholar
You J, Zhou O, Liu J, Zou W, Zhang L, Tian D, et al. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by affecting cell survival and angiogenesis. Stem Cells Dev. 2020;29(23):152032.
Article CAS PubMed Google Scholar
Tebyanian H, Karami A, Motavallian E, Samadikuchaksaraei A, Arjmand B, Nourani MR. Rat lung decellularization using chemical detergents for lung tissue engineering. Biotech Histochem. 2019;94(3):21422.
Article CAS PubMed Google Scholar
Weymann A, Patil NP, Sabashnikov A, Korkmaz S, Li S, Soos P, et al. Perfusion-decellularization of Porcine Lung and Trachea for respiratory bioengineering. Artif Organs. 2015;39(12):102432.
Article CAS PubMed Google Scholar
Prakash YS, Tschumperlin DJ, Stenmark KR. Coming to terms with tissue engineering and regenerative medicine in the lung. Am J Physiol Lung Cell Mol Physiol. 2015;309(7):L62538.
Article CAS PubMed PubMed Central Google Scholar
Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng. 2011;13:2753.
Article CAS PubMed PubMed Central Google Scholar
Hess C, Wiegmann B, Maurer AN, Fischer P, Mller L, Martin U, et al. Reduced thrombocyte adhesion to endothelialized poly 4-methyl-1-pentene gas exchange membranesa first step toward bioartificial lung development. Tissue Eng Part A. 2010;16(10):304353.
Article CAS PubMed Google Scholar
Dhasmana A, Singh A, Rawal S. Biomedical grafts for tracheal tissue repairing and regeneration tracheal tissue engineering: an overview. J Tissue Eng Regen Med. 2020;14(5):65372.
Article CAS PubMed Google Scholar
Bogan SL, Teoh GZ, Birchall MA. Tissue Engineered airways: a prospects article. J Cell Biochem. 2016;117(7):1497505.
Article CAS PubMed Google Scholar
Ruszymah BH, Chua K, Latif MA, Hussein FN, Saim AB. Formation of in vivo tissue engineered human hyaline cartilage in the shape of a trachea with internal support. Int J Pediatr Otorhinolaryngol. 2005;69(11):148995.
Article PubMed Google Scholar
Kanzaki M, Yamato M, Hatakeyama H, Kohno C, Yang J, Umemoto T, et al. Tissue engineered epithelial cell sheets for the creation of a bioartificial trachea. Tissue Eng. 2006;12(5):127583.
Article PubMed Google Scholar
Luo X, Liu Y, Zhang Z, Tao R, Liu Y, He A, et al. Long-term functional reconstruction of segmental tracheal defect by pedicled tissue-engineered trachea in rabbits. Biomaterials. 2013;34(13):333644.
Article CAS PubMed Google Scholar
Tsao CK, Ko CY, Yang SR, Yang CY, Brey EM, Huang S, et al. An ectopic approach for engineering a vascularized tracheal substitute. Biomaterials. 2014;35(4):116375.
Article CAS PubMed Google Scholar
Clark ES, Best C, Onwuka E, Sugiura T, Mahler N, Bolon B, et al. Effect of cell seeding on neotissue formation in a tissue engineered trachea. J Pediatr Surg. 2016;51(1):4955.
Article PubMed Google Scholar
Best CA, Pepper VK, Ohst D, Bodnyk K, Heuer E, Onwuka EA, et al. Designing a tissue-engineered tracheal scaffold for preclinical evaluation. Int J Pediatr Otorhinolaryngol. 2018;104:15560.
Article PubMed Google Scholar
Dharmadhikari S, Liu L, Shontz K, Wiet M, White A, Goins A, et al. Deconstructing tissue engineered trachea: assessing the role of synthetic scaffolds, segmental replacement and cell seeding on graft performance. Acta Biomater. 2020;102:18191.
Article CAS PubMed Google Scholar
Gao M, Zhang H, Dong W, Bai J, Gao B, Xia D, et al. Tissue-engineered trachea from a 3D-printed scaffold enhances whole-segment tracheal repair. Sci Rep. 2017;7(1):5246.
Article PubMed PubMed Central Google Scholar
Park HS, Park HJ, Lee J, Kim P, Lee JS, Lee YJ, et al. A 4-Axis technique for three-Dimensional Printing of an Artificial Trachea. Tissue Eng Regen Med. 2018;15(4):41525.
Article CAS PubMed PubMed Central Google Scholar
Lin CH, Hsu SH, Su JM, Chen CW. Surface modification of poly(-caprolactone) porous scaffolds using gelatin hydrogel as the tracheal replacement. J Tissue Eng Regen Med. 2011;5(2):15662.
Article CAS PubMed Google Scholar
Jung SY, Tran AN, Kim HY, Choi E, Lee SJ, Kim HS. Development of Acellular Respiratory Mucosal Matrix using Porcine Tracheal Mucosa. Tissue Eng Regen Med. 2020;17(4):43343.
Article CAS PubMed PubMed Central Google Scholar
Kobayashi K, Suzuki T, Nomoto Y, Tada Y, Miyake M, Hazama A, et al. A tissue-engineered trachea derived from a framed collagen scaffold, gingival fibroblasts and adipose-derived stem cells. Biomaterials. 2010;31(18):485563.
Article CAS PubMed Google Scholar
Okano W, Nomoto Y, Wada I, Kobayashi K, Miyake M, Nakamura T, et al. Bioengineered trachea with fibroblasts in a rabbit model. Ann Otol Rhinol Laryngol. 2009;118(11):796804.
Article PubMed Google Scholar
Weidenbecher M, Henderson JH, Tucker HM, Baskin JZ, Awadallah A, Dennis JE. Hyaluronan-based scaffolds to tissue-engineer cartilage implants for laryngotracheal reconstruction. Laryngoscope. 2007;117(10):17459.
Article CAS PubMed PubMed Central Google Scholar
Go T, Jungebluth P, Baiguero S, Asnaghi A, Martorell J, Ostertag H, et al. Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J Thorac Cardiovasc Surg. 2010;139(2):43743.
Article CAS PubMed Google Scholar
Mohd Heikal MY, Aminuddin BS, Jeevanan J, Chen HC, Sharifah SH, Ruszymah BH. Autologous implantation of bilayered tissue-engineered respiratory epithelium for tracheal mucosal regenesis in a sheep model. Cells Tissues Organs. 2010;192(5):292302.
Article CAS PubMed Google Scholar
Ozpolat B, Gurpinar A, Ayva E, Gazyagci S, Niyaz M. The effect of basic fibroblast growth factor and adipose tissue-derived mesenchymal stem cells on wound healing, epithelization and angiogenesis in a tracheal resection and end-to-end anastomosis rat model. Turkish J Thorac Cardiovasc Surg. 2013;21:10109.
Article Google Scholar
Jang YS, Jang CH, Cho YB, Kim M, Kim GH. Tracheal regeneration using polycaprolactone/collagen-nanofiber coated with umbilical cord serum after partial resection. Int J Pediatr Otorhinolaryngol. 2014;78(12):223743.
Article PubMed Google Scholar
Tatekawa Y, Kawazoe N, Chen G, Shirasaki Y, Komuro H, Kaneko M. Tracheal defect repair using a PLGA-collagen hybrid scaffold reinforced by a copolymer stent with bFGF-impregnated gelatin hydrogel. Pediatr Surg Int. 2010;26(6):57580.
Article PubMed Google Scholar
Shin YS, Lee BH, Choi JW, Min BH, Chang JW, Yang SS, et al. Tissue-engineered tracheal reconstruction using chondrocyte seeded on a porcine cartilage-derived substance scaffold. Int J Pediatr Otorhinolaryngol. 2014;78(1):328.
Article PubMed Google Scholar
Lee DY, Lee JH, Ahn HJ, Oh SH, Kim TH, Kim HB, et al. Synergistic effect of laminin and mesenchymal stem cells on tracheal mucosal regeneration. Biomaterials. 2015;44:13442.
Article CAS PubMed Google Scholar
Park JH, Hong JM, Ju YM, Jung JW, Kang HW, Lee SJ, et al. A novel tissue-engineered trachea with a mechanical behavior similar to native trachea. Biomaterials. 2015;62:10615.
Article CAS PubMed Google Scholar
Ghorbani F, Moradi L, Shadmehr MB, Bonakdar S, Droodinia A, Safshekan F. In-vivo characterization of a 3D hybrid scaffold based on PCL/decellularized aorta for tracheal tissue engineering. Mater Sci Eng C Mater Biol Appl. 2017;81:7483.
Article CAS PubMed Google Scholar
Park JH, Park JY, Nam IC, Ahn M, Lee JY, Choi SH, et al. A rational tissue engineering strategy based on three-dimensional (3D) printing for extensive circumferential tracheal reconstruction. Biomaterials. 2018;185:27683.
Article CAS PubMed Google Scholar
Wu T, Zhang J, Wang Y, Li D, Sun B, El-Hamshary H, et al. Fabrication and preliminary study of a biomimetic tri-layer tubular graft based on fibers and fiber yarns for vascular tissue engineering. Mater Sci Eng C Mater Biol Appl. 2018;82:1219.
Article CAS PubMed Google Scholar
Giraldo-Gomez DM, Garca-Lpez SJ, Tamay-de-Dios L, Snchez-Snchez R, Villalba-Caloca J, Sotres-Vega A, et al. Fast cyclical-decellularized trachea as a natural 3D scaffold for organ engineering. Mater Sci Eng C Mater Biol Appl. 2019;105:110142.
Article CAS PubMed Google Scholar
Varma R, Aoki FG, Soon K, Karoubi G, Waddell TK. Optimal biomaterials for tracheal epithelial grafts: an in vitro systematic comparative analysis. Acta Biomater. 2018;81:14657.
Article CAS PubMed Google Scholar
OLeary C, Cavanagh B, Unger RE, Kirkpatrick CJ, ODea S, OBrien FJ, et al. The development of a tissue-engineered tracheobronchial epithelial model using a bilayered collagen-hyaluronate scaffold. Biomaterials. 2016;85:11127.
Article PubMed Google Scholar
Ghaedi M, Niklason LE, Williams J. Development of Lung Epithelium from Induced Pluripotent Stem cells. Curr Transpl Rep. 2015;2(1):819.
Original post:
Advancements in lung regeneration: from bench to bedside
Top 3 Grants in Regenerative Medicine: January 2025 RegMedNet
Read more here:
Top 3 Grants in Regenerative Medicine: January 2025 - RegMedNet
Continue reading here:
Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized...
Cell therapy weekly: iPSC therapy IND for Phase III trial cleared RegMedNet
Read the original here:
Cell therapy weekly: iPSC therapy IND for Phase III trial cleared - RegMedNet
The rest is here:
Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location -...
Placental Stem Cell Therapy Solution Market Size And Booming openPR
Read this article:
Placental Stem Cell Therapy Solution Market Size And Booming - openPR
Original post:
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz - EIN News
Common symptoms of rheumatoid arthritis include:
RA affects people differently. In some people, RA starts with mild or moderate inflammation affecting just a few joints. However, if it is not treated or the treatments are not working, RA can worsen and affect more joints. This can lead to more damage and disability.
At times, RA symptoms worsen in flares due to a trigger such as stress, environmental factors (such as cigarette smoke or viral infections), too much activity, or suddenly stopping medications. In some cases, there may be no clear cause.
The goal of treatment is to control the disease so it is in remission or near remission, with no signs or symptoms of the disease.
Rheumatoid arthritis can cause other medical problems, such as:
Rheumatoid arthritis can happen in any joint; however, it is more common in the wrists, hands, and feet. The symptoms often happen on both sides of the body, in a symmetrical pattern. For example, if you have RA in the right hand, you may also have it in the left hand.
RA affects people differently. In some people, RA starts with mild or moderate inflammation affecting just a few joints. However, if it is not treated or the treatments are not working, RA can worsen and affect more joints. This can lead to more damage and disability.
At times, RA symptoms worsen in flares due to a trigger such as stress, environmental factors (such as cigarette smoke or viral infections), too much activity, or suddenly stopping medications. In some cases, there may be no clear cause.
The goal of treatment is to control the disease so it is in remission or near remission, with no signs or symptoms of the disease.
Rheumatoid arthritis can cause other medical problems, such as:
Follow this link:
Rheumatoid Arthritis | Health Topics | NIAMS
What Is Arthritis?
When people talk about having arthritis, they are usually talkingabout problems with their joints. The problems can affect any joint in the body, including:
There are many different types of arthritis with different causes and treatments. This webpage is going to give you information and tips on living with osteoarthritis (OA). It is the most common type of arthritis and is more common in older people.
OA can be painful, but there are things you can do to feel better. By learning about the disease and taking part in your care, you can learn to manage the symptoms to help you live an active lifestyle.
For more information about OA and other types of arthritis, please browse the NIAMS Health Topics.
When you have OA, you may feel:
Pain and other joint symptoms may lead you to feel tired, have problems sleeping, and feel depressed.
Remember, there are things you can do to help improve your joint pain and stiffness. It is important to visit your doctor, who can suggest and prescribe treatments that may lessen your pain and help you feel better. Be sure to keep track of your symptoms so your doctor has a full picture of what you are feeling. Also, bring a list of medications and supplements you take to your doctor appointment. Download the PDF at the top of this page for a printable booklet that includes tools such as a medication tracker, symptom tracker, and daily activity tracker.
There is no one test that shows if you have OA. Your doctor may:
The goals of your treatment may include:
You may see several types of doctors for your OA, including your family doctor, a rheumatologist, or other specialists who can work with you to treat your joint problems.
Treating OA usually includes:
Some people may need medications to help manage the symptoms of OA. Your doctor may recommend surgery if your joint problems are severe and all other treatments tried have not helped. However, surgery is not right for everyone, and your doctor will help you decide if its best for you.
You may hear or read about other types of therapies to help treat your OA. For example:
Before taking any medicines or using other therapies, talk to your doctor.
There are many things you can do to help manage and live with OA. Start by working with your doctor to set up a treatment plan that works for you.
Learning as much as you can about OA from reliable sources can help, too. Some people find it helpful to take a class or talk with a community health worker to learn about the disease and how to manage the symptoms to allow you to live an active lifestyle.
You may feel sadness or frustration when living with osteoarthritis. But keep in mind, many people with this disease live full lives. You may find it helpful to look for a support group, online or in your community. Support groups can help you connect with others living with OA, and offer tips on how to manage your joint problems.
For a list of possible organizations to contact, see the Other Resources section below.
Here are some other tips that may help:
Scientists supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), are working to find out what causes OA and other forms of arthritis and how they can best be treated.
Researchers are looking at these issues:
In addition, studies continue to:
A clinical trial is a type of research study that involves people who volunteer to take part in it. Most clinical trials test a new treatment for a health problem, like a new drug or diet. Clinical trials help doctors learn if a new treatment is better, the same, or worse than standard care. Other clinical trials test ways to prevent a disease or find it early.
Talk to your doctor about whether a clinical trial would be right for you. When you volunteer to take part in clinical research, you help doctors and researchers learn more about arthritis.
Also, when you participate in a study, you may have the chance to receive the newest treatment and have additional care from the clinical trial staff.
To learn more about the basics of participating in a clinical trial, visit the website NIH Clinical Research Trials and You.
At that website you will find:
To hear from people who have taken part in clinical studies led by NIAMS researchers, watch these videos.
National Institutes of Health 1 AMS CircleBethesda, MD 20892-3675Phone: 301-495-4484Toll free: 877-22-NIAMS (226-4267). For telecommunications support, dial 711Fax: 301-718-6366Email: [emailprotected]Website: niams.nih.gov
Find more information about osteoarthritis.
If you need more information about available resources in your language or another language, please visit our website or contact the NIAMS Information Clearinghouse.
U.S. Food and Drug AdministrationToll free: 888-INFO-FDA (888-463-6332)
National Center for Complementary and Integrative Health
National Institute on Aging
American Academy of Orthopaedic Surgeons
American College of Rheumatology
American Physical Therapy Association
Arthritis Foundation
Original post:
Living With Arthritis: Health Information Basics for You and Your ...